Skip to content
★ Sign in to follow
GI

Genethera Inc Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by MILICI ANTONIO, was filed 05 Jan 2012.

Genethera Inc: what insiders have been doing

This page follows insider dealings at Genethera Inc as filed with SEC (Form 4). No insider at Genethera Inc has published a filing in the past twelve months. The most recent one dates from 5 January 2012.

Since 2006, the database holds 21 purchases and 1 sale by insiders of the company.

Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Insider Decl.
23
Thresholds
n/a
Buy Volume
€308,110
21 ops. · all time
Sell Volume
€307
1 ops. · all time
Last declaration on 5 January 2012
Declarations23 total
  • ▲
    Chairman of the Board & CEOExecutives
    128,000 USD0SEC
    6,400,000 shares@ US$0.02Preferred B StockSEC:0001284050-12-000001:0
    Canonical exit: 3 Apr 2012 (T+90)
  • ▲
    Chief Administrative OfficerExecutives
    107,600 USD0SEC
    2,690,000 shares@ US$0.04Preferred B StockSEC:0001284142-12-000003:0
    Canonical exit: 30 Mar 2012 (T+90)
  • ▲
    Chairman of the Board; CEOExecutives
    128,000 USD0SEC
    6,400,008 shares@ US$0.02Preferred B StockSEC:0001284142-12-000001:0
    Canonical exit: 3 Apr 2012 (T+90)
  • ▲
    10% OwnerExecutives
    338 USD0SEC
    13,000 shares@ US$0.026Common StockSEC:0001412294-08-000001:0
    Canonical exit: 16 Mar 2008 (T+90)
  • ▲
    10% OwnerExecutives
    810 USD0SEC
    30,000 shares@ US$0.027Common StockSEC:0001412294-08-000001:1
    Canonical exit: 17 Mar 2008 (T+90)
  • ▲
    10% OwnerExecutives
    2,750 USD0SEC
    100,000 shares@ US$0.0275Common StockSEC:0001412294-08-000001:2
    Canonical exit: 18 Mar 2008 (T+90)
  • ▲
    10% OwnerExecutives
    700 USD0SEC
    25,000 shares@ US$0.028Common StockSEC:0001412294-08-000001:3
    Canonical exit: 14 Apr 2008 (T+90)
  • ▲
    10% OwnerExecutives
    2,750 USD0SEC
    100,000 shares@ US$0.0275Common StockSEC:0001412294-08-000001:4
    Canonical exit: 14 Apr 2008 (T+90)
  • ▲
    10% OwnerExecutives
    1,350 USD0SEC
    50,000 shares@ US$0.027Common StockSEC:0001412294-08-000001:5
    Canonical exit: 14 Apr 2008 (T+90)
  • ▲
    10% OwnerExecutives
    156 USD0SEC
    6,000 shares@ US$0.026Common StockSEC:0001412294-08-000001:6
    Canonical exit: 16 Apr 2008 (T+90)
  • ▼
    10% OwnerExecutives
    450 USD0SEC
    20,000 shares@ US$0.0225Common StockSEC:0001412294-08-000001:7
  • ▲
    10% OwnerExecutives
    2,970 USD0SEC
    135,000 shares@ US$0.022Common StockSEC:0001412294-08-000001:8
    Canonical exit: 19 May 2008 (T+90)
  • ▲
    10% OwnerExecutives
    5,000 USD0SEC
    200,000 shares@ US$0.025Common StockSEC:0001412294-08-000001:9
    Canonical exit: 25 May 2008 (T+90)
  • ▲
    10% OwnerExecutives
    720 USD0SEC
    30,000 shares@ US$0.024Common StockSEC:0001412294-07-000004:0
    Canonical exit: 22 Jan 2008 (T+90)
  • ▲
    10% OwnerExecutives
    3,450 USD0SEC
    150,000 shares@ US$0.023Common StockSEC:0001412294-07-000004:1
    Canonical exit: 23 Jan 2008 (T+90)
  • ▲
    10% OwnerExecutives
    792 USD0SEC
    33,000 shares@ US$0.024Common StockSEC:0001412294-07-000004:2
    Canonical exit: 27 Jan 2008 (T+90)
  • ▲
    10% OwnerExecutives
    1,962 USD0SEC
    109,000 shares@ US$0.018Common StockSEC:0001412294-07-000004:3
    Canonical exit: 27 Feb 2008 (T+90)
  • ▲
    10% OwnerExecutives
    4,400 USD0SEC
    200,000 shares@ US$0.022Common StockSEC:0001412294-07-000004:4
    Canonical exit: 27 Feb 2008 (T+90)
  • ▲
    10% OwnerExecutives
    5,300 USD0SEC
    265,000 shares@ US$0.02Common StockSEC:0001412294-07-000003:0
    Canonical exit: 20 Dec 2007 (T+90)
  • ▲
    10% OwnerExecutives
    4,032 USD0SEC
    192,000 shares@ US$0.021Common StockSEC:0001412294-07-000003:1
    Canonical exit: 1 Jan 2008 (T+90)
  • ▲
    10% OwnerExecutives
    1,610 USD0SEC
    70,000 shares@ US$0.023Common StockSEC:0001412294-07-000003:2
    Canonical exit: 10 Jan 2008 (T+90)
  • ▲
    10% OwnerExecutives
    2,775 USD0SEC
    150,000 shares@ US$0.0185Common StockSEC:0001412294-07-000002:0
    Canonical exit: 22 Nov 2007 (T+90)
  • ◆
    Chief Financial OfficerExecutives
    4,500 USD0SEC
    45,000 shares@ US$0.10Common StockSEC:0001298437-06-000002:0

23 of 23 declarations

About Genethera Inc

Genethera Inc is a company listed on the XNAS market, focused on developing innovative therapeutic solutions. It specializes in research and treatment for genetic diseases.